Sort by
Refine Your Search
-
biopharmaceuticals. The research at CMB pushes the boundaries of biomolecular and bioinformatics research and engineering technologies. VIB.AI studies fundamental problems in biology by combining machine learning with
-
researcher to join our enthusiastic and young interdisciplinary teams of Prof. Dmitriev (Tissue Engineering and Biomaterials Group) and Prof. Vergult (Functional Genomics lab), as part of the MINDFUL research
-
: https://cbd.sites.vib.be/en/technology Joris de Wit lab: https://dewitlab.sites.vib.be/en Anthony Holtmaat lab: https://neurocenter-unige.ch/research-groups/anthony-holtmaat/
-
, technology development, and bioinformatics. VIB provides a highly interactive environment and ample training opportunities for its researchers. The opportunity to contribute to groundbreaking research in
-
5 Mar 2025 Job Information Organisation/Company Université catholique de Louvain Department Louvain Institute of Biomolecular Science and Technology (LIBST) Research Field Biological sciences
-
://www.imec-int.com/en/home ) (prof. C. Fleischmann). Profile You hold a PhD in computer science, physics, mathematics or engineering (or you will have obtained it by the time you start work). You have
-
media formats, including television, film, digital platforms, and live events. Technology and Innovation: Exploring the role of emerging technologies in enhancing media accessibility. This could involve
-
collaborations and access to centralized facilities with expertise in genomics, functional genomics and cell biology, cutting-edge microscopy, flow cytometry, technology development, and bioinformatics. VIB
-
Biology, Physics, Mechanical Engineering, or equivalent (or you will have obtained it by the time you start work). You have a strong affinity for research on functional morphology. Your research qualities
-
postdoctoral researcher - molecular mechanisms T-cell leukemia - Diagnostische Wetenschappen (28449)
expertise in genetic engineering, development of high throughput drug screening assays, generation of in vitro and in vivo cancer models to evaluate novel therapeutic strategies to combat aggressive subtypes